Nanotech, immunotherapy combo vaccinates mouse against cancer
Researchers from Duke University combined an FDA-approved cancer immunotherapy with gold nanostars to boost the cancer-killing abilities of both therapies, according to a study published this week in Scientific Reports.
The combination therapy cured two mice and vaccinated one against bladder cancer, the team reported.
Get the full story at our sister site, Drug Delivery Business News.
The post Nanotech, immunotherapy combo vaccinates mouse against cancer appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Oncology Pharmaceuticals Research & Development Duke University Source Type: news
More News: Bladder Cancer | Cancer | Cancer & Oncology | Cancer Vaccines | Immunotherapy | Medical Devices | Nanotechnology | Study | Vaccines